Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: '7 xylosyltaxol'

Search results for: '7 xylosyltaxol'

Items 11-20 of 127

Page
per page
  1. Fostriecin sodium salt
    A4536 Fostriecin sodium salt
    Target: PP1|PP2A|Topoisomerases|PP4
    Summary: Antitumor antibiotic
      Soluble in H2O
  2. Lapatinib Ditosylate
    A3967 Lapatinib Ditosylate
    Target: EGFR|ErbB-2
    Summary: EGFR/HER2 inhibitor,potent and selective
      ≥24.3 mg/mL
  3. GDC-0941
    A8210 GDC-0941
     10 Citation
    Target: PI3K
    Summary: PI3K inhibitor,potent and selective
      ≥25.7 mg/mL
  4. TAK-632
    A8226 TAK-632
    Target: Raf
    Summary: Pan-RAF inhibitor,potent and selective
      ≥27.75 mg/mL
  5. ML161
    A8229 ML161
    Target: Protease-Activated Receptors
    Summary: PAR1 inhibitor
      insoluble in H2O; ≥16.4 mg/mL
  6. GDC-0879
    A5071 GDC-0879
     1 Citation
    Target: Raf
    Summary: B-Raf inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL
  7. PHA-665752
    A2307 PHA-665752
     1 Citation
    Target: c-MET
    Summary: C-Met inhibitor,potent and ATP-competitive
  8. Fluoxetine HCl
    A2436 Fluoxetine HCl
    Target: Serotonin (5-HT) reuptake
    Summary: Serotonin reuptake inhibitor,selective
      insoluble in H2O; ≥17.3 mg/mL
  9. SB202190 (FHPI)
    A1632 SB202190 (FHPI)
     5 Citation
    Target: p38
    Summary: P38 MAPK inhibitor
  10. TG100-115
    A2754 TG100-115
    Target: PI3K
    Summary: PI3Kγ/PI3Kδ inhibitor
      insoluble in H2O; insoluble in EtOH; ≥3.46 mg/mL

Items 11-20 of 127

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 6item
  2. Apoptosis 8item
  3. Chromatin/Epigenetics 11item
  4. Metabolism 9item
  5. MAPK Signaling 6item
  6. Tyrosine Kinase 17item
  7. DNA Damage/DNA Repair 9item
  8. PI3K/Akt/mTOR Signaling 8item
  9. Microbiology & Virology 7item
  10. Cell Cycle/Checkpoint 7item
  11. Ubiquitination/ Proteasome 6item
  12. JAK/STAT Signaling 3item
  13. TGF-β / Smad Signaling 3item
  14. Angiogenesis 1 item
  15. GPCR/G protein 10item
  16. Stem Cell 2item
  17. Membrane Transporter/Ion Channel 8item
  18. Cancer Biology 1 item
  19. Endocrinology and Hormones 3item
  20. Neuroscience 13item
  21. Other Signal Transduction 2item
  22. Others 7item
  23. Immunology/Inflammation 3item
  24. Cardiovascular 1 item
  25. NF-κB 1 item
Specificity
  1. Selective 69item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 5item
  2. Irreversible 2item
Target
  1. Caspases 2item
  2. Cyclin-Dependent Kinases 4item
  3. Proteasome 3item
  4. Histone Deacetylases (HDACs) 6item
  5. PI3K 4item
  6. Raf 4item
  7. CSF-1R 1 item
  8. FLT3 2item
  9. GSK-3 2item
  10. Factor Xa 1 item
  11. PLK 1 item
  12. VEGFR 6item
  13. PDGFR 4item
  14. c-Kit 2item
  15. RET 1 item
  16. p38 2item
  17. MEK 1 item
  18. FGFR 2item
  19. Nrf2 1 item
  20. Voltage-gated Sodium (NaV) Channels 1 item
  21. Deubiquitinating enzymes (DUBs) 1 item
  22. PP1 1 item
  23. PP2A 1 item
  24. MET 1 item
  25. Src 1 item
  26. Trk Receptors 1 item
  27. NMDA Receptors 1 item
  28. STAT 1 item
  29. EGFR 2item
  30. Reverse Transcriptases 1 item
  31. ROCK 1 item
  32. JAK 1 item
  33. Topoisomerases 3item
  34. Cytochrome P450 (CYP450) 1 item
  35. Toll-like receptors (TLRs) 1 item
  36. HMG-CoA Reductases 1 item
  37. c-MET 3item
  38. PKC 2item
  39. Protease-Activated Receptors 1 item
  40. HER2 1 item
  41. 5-HT2 Receptors 1 item
  42. DGAT 1 item
  43. Insulin and Insulin-like Receptors 1 item
  44. PARP 2item
  45. CB1 Receptors 1 item
  46. ALK 3item
  47. PKG 1 item
  48. PKA 1 item
  49. Myosin light chain kinases (MLCKs) 2item
  50. D2 Receptors 1 item
  51. 5-HT1 Receptors 1 item
  52. 5-HT7 Receptors 1 item
  53. 5-HT3 Receptors 1 item
  54. Autophagy 1 item
  55. COX 4item
  56. Squalene epoxidases 1 item
  57. P2X Receptors 1 item
  58. Ron 1 item
  59. Synthases/Synthetases 1 item
  60. Histamine H1 Receptors 1 item
  61. Phospholipases 1 item
  62. Calcium-Activated Potassium (KCa) Channels 1 item
  63. AChE 1 item
  64. cAMP 1 item
  65. Sulfonylurea receptors 1 item
  66. Peptidoglycan synthesis 1 item
  67. Nuclear Receptors 1 item
  68. Catechol O-Methyltransferase (COMT) 1 item
  69. Angiotensin AT1 Receptors 1 item
  70. Hydroxylases 1 item
  71. DREADD Ligands 1 item
  72. PP4 1 item
  73. AChR 1 item
  74. sodium channels 1 item
  75. Fyn kinase 1 item
  76. KDM 1 item
  77. Ub-conjugating enzyme (E2) complex 1 item
  78. Nrf2/ARE signal 1 item
  79. PPAR 2item
  80. PC-PLC 1 item
  81. P97 ATPase 1 item
  82. Antibiotic 1 item
  83. Hec1 1 item
  84. Calmodulins 1 item
  85. ErbB-2 1 item
  86. adrenergic receptor 1 item
  87. TRPA 1 item
  88. Histone Acetyltransferases (HATs) 1 item
  89. constitutive androstane receptor (CAR) 1 item
  90. Tyrosinases 1 item
  91. ITK 1 item
  92. NUAK 1 item
  93. SERT 1 item
  94. prolactin secretion 1 item
  95. gonadotropin release 1 item
  96. 5-HT receptor 1 item
  97. NOP Receptors 1 item
  98. Transferases 1 item
  99. Dopamine receptor 1 item
  100. Histamine receptor 1 item
  101. Octamer-binding transcription factor 4 (Oct4) 1 item
  102. GLP-2 receptor 1 item
  103. PRMT 1 item
  104. epoxide hydrolase 1 item
  105. Serotonin (5-HT) reuptake 1 item
  106. NE 1 item
  107. PIKfyve 1 item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 1 item
  3. Anesthesia 1 item
  4. Bladder Cancer 1 item
  5. B-lymphoid Malignancies 1 item
  6. Brain Injuries Studies 1 item
  7. Breast Cancer 8item
  8. Cancer 46item
  9. Chronic Lymphocytic Leukemia 2item
  10. Cocaine-Related Disorders 1 item
  11. Colon Cancer 1 item
  12. Colorectal Cancer 7item
  13. Depression 1 item
  14. Diabetes 3item
  15. Glioblastoma 4item
  16. Glioma 1 item
  17. Hepatocellular Carcinoma 1 item
  18. HIV 1 item
  19. Lung Cancer 1 item
  20. Lung Carcinoma 1 item
  21. Lymphoma 4item
  22. Mantle Cell Lymphoma 2item
  23. Melanoma 3item
  24. Multiple Myeloma 4item
  25. Myeloma 1 item
  26. Neuroblastoma 2item
  27. Neurocognitive Disorders 1 item
  28. Non-small Cell Lung Cancer 3item
  29. Obsessive-Compulsive Disorder 1 item
  30. Ovarian Cancer 3item
  31. Pancreatic Cancer 2item
  32. Prostate Cancer 1 item
  33. Renal Cancer 1 item
  34. Rheumatoid Arthritis 1 item
  35. Schizophrenia 1 item
  36. Thyroid Cancer 1 item
  37. Type 2 Diabetes 2item